S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
OTCMKTS:OXBDF

Oxford Biomedica (OXBDF) Stock Price, News & Analysis

$2.43
0.00 (0.00%)
(As of 03/28/2024 ET)
Today's Range
$2.43
$2.43
50-Day Range
$2.09
$2.72
52-Week Range
$2.09
$6.02
Volume
200 shs
Average Volume
279 shs
Market Capitalization
$233.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
OXBDF stock logo

About Oxford Biomedica Stock (OTCMKTS:OXBDF)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, and adenoviral vectors. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.

OXBDF Stock Price History

OXBDF Stock News Headlines

Oxford BioMedica PLC (OXB)
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Oxford BioMedica PLC OXOA
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
See More Headlines
Receive OXBDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:OXBDF
Previous Symbol
NASDAQ:OXBDF
CIK
N/A
Fax
N/A
Employees
891
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$173.19 million
Book Value
$3.03 per share

Miscellaneous

Free Float
N/A
Market Cap
$233.91 million
Optionable
Not Optionable
Beta
1.14
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Stuart Paynter (Age 52)
    CFO & Director
    Comp: $1.06M
  • Dr. Frank Mathias (Age 62)
    CEO & Director
  • Mr. Thierry Cournez
    COO & Site Head of UK Operations
  • Dr. James Miskin Ph.D.
    Chief Quality & Technical Officer
  • Mr. Matthew Treagus
    Chief Information Officer & Chief of Staff
  • Sophia Bolhassan
    Head of Investor Relations
  • Ms. Natalie Louise Walter (Age 51)
    General Counsel & Company Secretary
  • Ms. Lisa James
    Chief People Officer
  • Dr. Kyriacos Mitrophanous Ph.D.
    Chief Innovation Officer
  • Ms. Kati Hudson
    Head of Intellectual Property and Contracts

OXBDF Stock Analysis - Frequently Asked Questions

Should I buy or sell Oxford Biomedica stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oxford Biomedica in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" OXBDF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OXBDF, but not buy additional shares or sell existing shares.
View OXBDF analyst ratings
or view top-rated stocks.

How have OXBDF shares performed in 2024?

Oxford Biomedica's stock was trading at $2.69 at the beginning of the year. Since then, OXBDF shares have decreased by 9.7% and is now trading at $2.43.
View the best growth stocks for 2024 here
.

Are investors shorting Oxford Biomedica?

Oxford Biomedica saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 600 shares, an increase of 100.0% from the February 29th total of 300 shares. Based on an average trading volume of 600 shares, the days-to-cover ratio is currently 1.0 days.
View Oxford Biomedica's Short Interest
.

How do I buy shares of Oxford Biomedica?

Shares of OXBDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:OXBDF) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners